Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -336.59%-727.56M | ---- | -169.87%-166.65M | ---- | 19.14%238.51M | ---- | -29.88%200.2M | ---- | -13.09%285.52M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -19.98%-33.79M | ---- | -224.65%-28.17M | ---- | 17.33%-8.68M | ---- | -11.18%-10.5M | ---- | 30.11%-9.44M |
| Dividend (income)- adjustment | ---- | ---- | ---- | 52.62%-334K | ---- | ---705K | ---- | ---- | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | 571.43%47K | ---- | --7K | ---- | ---- | ---- | ---- |
| Impairment and provisions: | ---- | 13,910.18%407.42M | ---- | -99.35%2.91M | ---- | 2,224.10%447.8M | ---- | -113.21%-21.08M | ---- | 38,014.25%159.62M |
| -Impairment of property, plant and equipment (reversal) | ---- | 574.66%303.6M | ---- | -84.23%45M | ---- | --285.4M | ---- | ---- | ---- | ---- |
| -Impairmen of inventory (reversal) | ---- | 358.72%104.83M | ---- | -137.44%-40.52M | ---- | 655.59%108.23M | ---- | -112.45%-19.48M | ---- | 16,922.04%156.45M |
| -Impairment of trade receivables (reversal) | ---- | 35.90%-1.01M | ---- | -193.41%-1.57M | ---- | 205.18%1.69M | ---- | -150.47%-1.6M | ---- | 523.58%3.17M |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | --52.49M | ---- | ---- | ---- | ---- |
| Revaluation surplus: | ---- | -84.55%2.45M | ---- | -65.45%15.86M | ---- | 222.40%45.89M | ---- | ---37.49M | ---- | ---- |
| -Derivative financial instruments fair value (increase) | ---- | -84.55%2.45M | ---- | -65.45%15.86M | ---- | 222.40%45.89M | ---- | ---37.49M | ---- | ---- |
| Asset sale loss (gain): | ---- | -40.70%-55.15M | ---- | 92.54%-39.2M | ---- | -8,217.50%-525.45M | ---- | 6.20%6.47M | ---- | -58.32%6.1M |
| -Available for sale investment sale loss (gain) | ---- | -4,166.70%-39.2M | ---- | --964K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---42.51M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -780.50%-15.95M | ---- | 100.45%2.34M | ---- | -8,217.50%-525.45M | ---- | 6.20%6.47M | ---- | -51.53%6.1M |
| Depreciation and amortization: | ---- | -19.10%674.82M | ---- | -18.63%834.15M | ---- | -4.33%1.03B | ---- | 13.09%1.07B | ---- | -7.26%947.46M |
| Financial expense | ---- | -14.84%182.73M | ---- | 76.49%214.56M | ---- | 90.55%121.57M | ---- | -30.90%63.8M | ---- | -32.69%92.33M |
| Special items | ---- | 98.24%-104K | ---- | 91.71%-5.9M | ---- | -22,930.45%-71.23M | ---- | 102.93%312K | ---- | 80.39%-10.65M |
| Operating profit before the change of operating capital | ---- | -45.51%450.8M | ---- | -35.00%827.27M | ---- | -0.03%1.27B | ---- | -13.44%1.27B | ---- | 2.60%1.47B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -46.10%344.11M | ---- | 446.31%638.48M | ---- | 148.77%116.87M | ---- | 63.01%-239.66M | ---- | -561.10%-647.92M |
| Accounts receivable (increase)decrease | ---- | 323.73%294.91M | ---- | -108.24%-131.82M | ---- | 841.30%1.6B | ---- | 64.88%-215.77M | ---- | -1,062.72%-614.4M |
| Accounts payable increase (decrease) | ---- | 71.64%-103.02M | ---- | 37.84%-363.23M | ---- | -632.02%-584.31M | ---- | -85.84%109.83M | ---- | 1,667.46%775.75M |
| prepayments (increase)decrease | ---- | -348.22%-36.99M | ---- | -90.02%14.9M | ---- | 856.26%149.3M | ---- | 110.67%15.61M | ---- | -274.51%-146.35M |
| Derivative financial instruments (increase) decrease | ---- | 99.95%-8K | ---- | 56.95%-17.53M | ---- | -219.65%-40.73M | ---- | --34.04M | ---- | ---- |
| Cash from business operations | -60.84%231.46M | -1.89%949.81M | 92.90%591.06M | -61.48%968.08M | -65.48%306.4M | 157.18%2.51B | -4.01%887.67M | 16.62%977.28M | 270.70%924.78M | -41.56%838.01M |
| China income tax paid | ---- | 47.85%-34.62M | ---- | 37.58%-66.39M | ---- | 34.75%-106.35M | ---- | -2.03%-163M | ---- | -8.28%-159.77M |
| Other taxs | 53.64%-12.1M | 89.28%-11.56M | 8.08%-26.1M | -290.58%-107.75M | 63.71%-28.39M | 34.05%-27.59M | 53.78%-78.24M | -1,364.23%-41.83M | -33.50%-169.27M | 33.22%-2.86M |
| Interest received - operating | -27.03%12.52M | 19.98%33.79M | 28.03%17.16M | 224.65%28.17M | 524.31%13.4M | -17.33%8.68M | -40.54%2.15M | 11.18%10.5M | -38.36%3.61M | -30.11%9.44M |
| Interest paid - operating | 18.37%-83.28M | 12.48%-196.09M | 9.76%-102.03M | -69.38%-224.05M | -138.28%-113.07M | -79.73%-132.28M | -21.77%-47.45M | 27.03%-73.6M | 35.58%-38.97M | 31.25%-100.86M |
| Net cash from operations | -69.05%148.61M | 23.96%741.34M | 169.19%480.1M | -73.49%598.06M | -76.66%178.35M | 218.02%2.26B | 6.11%764.13M | 21.47%709.35M | 958.42%720.15M | -49.17%583.97M |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | ---- | ---- | ---- | -52.62%334K | ---- | --705K | ---- | ---- | ---- | ---- |
| Restricted cash (increase) decrease | 1,522.77%6.37M | 152.59%4.85M | 96.74%-448K | 66.98%-9.22M | 64.52%-13.75M | 23.38%-27.92M | -8.41%-38.76M | -711.97%-36.43M | -73.39%-35.75M | -113.77%-4.49M |
| Sale of fixed assets | -54.87%36.21M | 662.23%118.28M | 133.12%80.24M | -83.68%15.52M | 389.11%34.42M | 127.42%95.11M | -66.52%7.04M | 1,240.91%41.82M | 1,075.45%21.02M | -95.64%3.12M |
| Purchase of fixed assets | -23.93%-345.44M | -199.72%-535.95M | -379.44%-278.74M | 67.27%-178.82M | 80.24%-58.14M | 47.57%-546.39M | 46.33%-294.27M | 16.84%-1.04B | -38.54%-548.29M | -65.86%-1.25B |
| Purchase of intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 78.79%-19.72M | ---- | ---93M |
| Sale of subsidiaries | ---- | ---- | ---- | --26.51M | --26.51M | ---- | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | --155.99M | 297.92%81.08M | ---- | --20.38M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash on investment | ---- | ---- | ---- | ---- | ---- | ---12.66M | ---- | ---- | ---- | ---- |
| Other items in the investment business | ---- | ---- | ---- | --13.22M | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from investment operations | 26.18%-146.87M | -196.01%-331.74M | -1,715.42%-198.95M | 77.18%-112.07M | 96.64%-10.96M | 53.51%-491.15M | 42.10%-325.99M | 21.60%-1.06B | -11.33%-563.02M | -117.73%-1.35B |
| Net cash before financing | -99.38%1.74M | -15.72%409.6M | 67.96%281.15M | -72.46%485.98M | -61.80%167.39M | 608.26%1.76B | 178.84%438.14M | 54.53%-347.21M | 135.90%157.13M | -244.12%-763.65M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -12.37%762.96M | -28.59%1.89B | -46.37%870.63M | -49.93%2.65B | -20.70%1.62B | 184.19%5.29B | 170.56%2.05B | -27.51%1.86B | -20.88%756.53M | 51.70%2.57B |
| Refund | 37.86%-627.06M | 32.58%-2.35B | 49.38%-1.01B | 42.25%-3.48B | 5.84%-1.99B | -295.91%-6.02B | -107.39%-2.12B | 16.87%-1.52B | -47.77%-1.02B | 9.91%-1.83B |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --49.83M |
| Dividends paid - financing | ---9.6M | ---- | ---- | 37.50%-60M | 37.50%-60M | 20.00%-96M | 20.00%-96M | -2.89%-120M | -2.89%-120M | 0.00%-116.63M |
| Other items of the financing business | ---- | ---- | ---- | -37.50%17.72M | -37.50%17.72M | -20.00%28.35M | -20.00%28.35M | 123.85%35.44M | 167.10%35.44M | -94.24%-148.56M |
| Net cash from financing operations | 162.18%125.4M | 39.22%-584.53M | 59.26%-201.68M | -15.02%-961.71M | -256.18%-495.06M | -431.57%-836.14M | 60.29%-138.99M | -51.43%252.17M | -469.52%-350.04M | 197.32%519.16M |
| Effect of rate | 135.22%4.53M | -100.89%-18.51M | 36.55%-12.87M | 86.91%-9.22M | -137.69%-20.28M | -570.40%-70.39M | -261.18%-8.53M | -51.87%14.96M | 144.12%5.29M | 367.40%31.09M |
| Net Cash | 59.99%127.14M | 63.23%-174.94M | 124.25%79.46M | -151.23%-475.73M | -209.53%-327.67M | 1,077.07%928.59M | 255.08%299.15M | 61.13%-95.04M | 43.75%-192.91M | -6,798.73%-244.49M |
| Begining period cash | -15.83%1.03B | -28.41%1.22B | -28.41%1.22B | 101.13%1.71B | 101.13%1.71B | -8.62%848.6M | -8.62%848.6M | -18.69%928.67M | -18.69%928.67M | -1.31%1.14B |
| Cash at the end | -9.96%1.16B | -15.83%1.03B | -5.18%1.29B | -28.41%1.22B | 19.28%1.36B | 101.13%1.71B | 53.73%1.14B | -8.62%848.6M | -5.85%741.06M | -18.69%928.67M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.